STEVEN GIRGENTI - 01 Jul 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Executive Chairman, Director
Signature
/s/ Maria Zannes, as attorney-in-fact for Steven Girgenti
Issuer symbol
BIAF
Transactions as of
01 Jul 2024
Net transactions value
$0
Form type
4
Filing time
02 Jul 2024, 18:47:13 UTC
Previous filing
14 Jun 2024
Next filing
14 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +33,784 +3.3% $0.000000 1,065,248 01 Jul 2024 Direct F1
holding BIAF Common Stock 8,955 01 Jul 2024 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024.
F2 These shares are owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.